Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tailored Exercise Training Study Among Adults With HFpEF
NCT07223242Phase 3Recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Feb 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in heart failure with preserved ejection fraction (HFpEF) and diabetic cardiomyopathy (DCM) (4 arms), sponsored by UT Southwestern Medical Center. Primary endpoints: Peak Exercise Oxygen Uptake at 9 months and Short Physical Performance Battery at 9 months. Started Feb 2025; status: recruiting.
02
Conditions
heart failure with preserved ejection fraction (HFpEF)diabetic cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT07223242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07223242.